A Texas jury recently ordered that Johnson & Johnson (NYSE:JNJ) must pay $1.2 million to a former nurse who was injured by one of the manufacturer’s mesh slings used to treat incontinence. Johnson & Johnson (NYSE:JNJ) stock performance was 0.91% in last session and finished the day at $98.95.
On March 28, 2014 a motion was filed to combine all of the lawsuits filed against AbbVie Inc. (NYSE:ABBV), and Abbott Laboratories, the manufacturers of Androgel, a testosterone therapy treatment. Plaintiffs asked the Judicial Panel on Multidistrict Litigation (JPML) to centralize all the cases to the U.S. District Court in Illinois. AbbVie Inc (NYSE:ABBV) rose 3.12 percent to $50.63 Wednesday on volume of 6.02million shares.
A U.S. jury ordered Japanese drugmaker Takeda Pharmaceutical Co. and its U.S. counterpart, Eli Lilly and Co. (NYSE:LLY), to pay $9 billion in punitive damages over a diabetes medicine linked to cancer. The drug companies said Tuesday they will “vigorously challenge” the decision. Eli Lilly and Co (NYSE:LLY)’s stock on Apr 09, 2014 reported a increase of 3.16% to the closing price of $60.43. Its fifty two weeks range is $47.53 -$60.46. The total market capitalization recorded $68.83billion.
IsoRay, Inc. (NYSEMKT:ISR) has been very volatile, after a healthy gain in its last week’s trading session,, the stock seems to have lost the momentum and is correcting from the previous high of 3.47 levels. The Momentum indicators have turned downwards that implies the stock may show a further downward bias from the current levels. On Wednesday, shares of IsoRay, Inc. (NYSEMKT:ISR) dropped -5.05% to close the day at $2.82.